Register your interest

Comments

Register your interest

Comments

Bio Connections Australia

Optimising Clinical Trials | Commercialising Great Science | Partnering for Growth

August 2019 | Melbourne

Register Your Interest

overview

Australia is well positioned to be a leading destination for early phase clinical trials, commencing over 1000 new trials each year. But how can we, and the rest of the world, further capitalise on this opportunity?

Bio Connections Australia is a brand new event designed to foster the growth of early phase clinical research in Australia. As a unique platform for networking and discussion, the conference will explore drug development, early phase clinical trials, translational research and expediting Australia’s great science into commercialisation.

Bringing together a mix of the nation’s industry executives, researchers, and academics, the two-day event will also be attended by international pharmaceutical and biotechnology companies looking to conduct clinical trial activity in Australia.

Conference agenda topics & features:

  • The opportunities and obstacles to early phase clinical trials in Australia vs International
  • Aussie biotech success stories & the path to commercial success
  • Optimising drug development in Australia
  • Global best practice tools & techniques for designing a clinical development programme
  • Leveraging Emerging Technologies Including Machine Learning & Deep Sequencing for Clinical Development
  • Medical device trials in Australia
  • Assessing partnerships in clinical trials
  • Translational research and expediting research into commercialization
  • Models for turning discovery into drugs
  • Finding the funding – navigating challenges and getting ahead of the pack
  • Government incentives for biotech, pharma and medtech companies in Australia
  • Recruitment and engagement in clinical trials across Australia
  • Mitigating risk and ensuring patient safety
  • Australia as a springboard into Asia – regional partnership opportunities
  • The regulatory environment in Australia & comparing international regulatory pathways
  • Governance, bureaucracy, ethics: How we cultivate innovation rather than stifling it
  • Driving greater collaboration across academia and industry

2018 Speakers

Kevin Wightman
ARCS Board Director, Senior Industry Executive & Clinical Development Solutions Consultant

Dr Dan Abrams
CEO, Cerebral Therapeutics, USA

Xiaowei Shi
Executive Director, Clinical Operations, Asia-Pacific, BeiGene

Jolanta Airey
Early Clinical Development Physician, Clinical Pharmacology Translational Development, CSL Limited

Sharon Charles
Director of Medical Affairs, Mesoblast

Brad Joblin
Chief Scientific Officer, Q-Pharm Pty Limited

Phil Kearney
Director External Licensing, MSD

Megan Ford
Senior Director Research & Development, IQVIA

Nicoletta Muner
Director, Global Regulatory Affairs’, CLINUVEL PHARMACEUTICALS

Dr Kilian Kelly
VP Product Development, Cynata Theraputics Ltd

Sameer Kassam
Partner, CharterNet

Michelle Gallaher
Managing Director, The Social Science

Roslyn Ristuccia
Co-Founder & CEO, ClinTrial Refer

Professor Lisa Askie
Director, Systematic Reviews & Health Technology Assessment, Manager, Australian New Zealand Clinical Trials Registry, NHMRC Clinical Trials Centre, Faculty of Medicine and Health, University of Sydney

Tam Nguyen
Executive Officer Research, St Vincent’s Hospital Melbourne

Pip Palmer
Therapeutic Area Head, MSD Australia and New Zealand

Chris Huang MD
CMO, Phagelux Inc & Phagelux Australia Pty Ltd

Mary Nteris
PhD, GAICD, Director and Consultant, Regulatory and Related Services

Professor Sean Grimmond
Director of Cancer Research & Bertalli Chair of Cancer Medicine, University of Melbourne Centre for Cancer Research

Dr Dan Grant
CEO, MTP Connect

Glenn Begley
Chief Executive Officer, BioCurate Pty Ltd

Karyn Joyner
Chief Operating Officer, SPHERE Maridulu Budyari Gumal

Brett Roberts
Head of Strategic Partnerships, Novartis Pharmaceuticals Australia Pty Ltd

Dr Tina Soulis
Chief Executive Officer, Neuroscience Trials Australia

Anita Van Der Meer
Clinical Research Manager, Medtronic

Ben Wright
Chief Innovation Officer & Head of Investment Strategy, Cicada Innovations

Dr Campbell Spence
R&D Tax Incentive Consultant

Anne O’Neill
Director, Office for Health and Medical Research, NSW Ministry of Health

Professor Nikolai Petrovsky
Founder & Research Director, Vaxine and Professor, Flinders University

Professor Andrew Davidson
Medical Director, Melbourne Children’s Trials Centre (MCTC) Murdoch Childrens Research Institute, Senior Staff Anaesthetist and Director of Clinical Research for the Royal Children’s Hospital

Associate Professor Dimitar Sajkov
Flinders University of South Australia, Senior Staff Specialist, Southern Adelaide Local Health Network, Research Director, Australian Respiratory and Sleep Medicine Institute

Gordon McGurk Ph.D.
GAICD, Chair, Royal Brisbane and Women’s Hospital HREC

Dr Megan Robertson
Director of Research – Research Directorate, St Vincent’s Hospital Melbourne & Chair of the Clinical Trials Ready Development Committee

Dr David Fuller
SVP Clinical Development Oncology, Syneos Health

Karen West
Executive Director Clinical Development Early Phase, Syneos Health

Sara Prickett
Chief Scientific Officer, Aravax

Michael Bettess
Investment Manager, Brandon Capital Partners

Alan Baghdasarayan
Senior Manager, CharterNet

Dr. Graeme Wald
Principal, OneVentures

Michael James
Chair Human Research Ethics Committee, Bellberry Limited

Brett Carter
CEO, Cancer Therapeutics CRC

Mohan Vallipuram
Regulatory Affairs Manager, ACRUX DDS Pty Ltd

Adriana Stefancic
Principal Consultant and Managing Director, Adriaus Consulting

Sponsors, Exhibitors & Partners Included

when & where

13 - 14 Nov 2018

contact

Still have a question?

Frankie Brewer
Conference Manager
+61 2 9080 4015
Francesca.Brewer@informa.com

Danielle Newman
Business Development Executive
+61 (2) 9080 4432
Danielle.Newman@informa.com

Get all the latest on Informa news and events

Informa Australia is the nation's leading event organiser. Our events comprise of large scale exhibitions, industry conferences and highly specialised corporate training.

Find out more